← FDA DRUG APPROVALS

FDA ANDA · ANDA040564

NIGHTTIME SLEEP-AID

doxylamine succinate

Sponsor: LNK

APPLICATION
ANDA040564
TYPE
ANDA
ORIGINAL APPROVAL
2004-08-27
LATEST ACTION
2004-08-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Over-the-counter

Products

DOXYLAMINE SUCCINATEOver-the-counter
DOXYLAMINE SUCCINATE 25MG · TABLET · ORAL

Approval history

2004-08-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →